Insider Selling: Luminex Corp. CFO Sells 30,000 Shares of Stock (LMNX)
Luminex Corp. (NASDAQ:LMNX) CFO Harriss Currie unloaded 30,000 shares of the company’s stock on the open market in a transaction dated Monday, September 23rd. The shares were sold at an average price of $19.88, for a total transaction of $596,400.00. Following the sale, the chief financial officer now directly owns 167,748 shares in the company, valued at approximately $3,334,830. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at TheStreet downgraded shares of Luminex Corp. (NASDAQ:LMNX) from a “buy” rating to a “hold” rating in a research note to investors on Wednesday, August 21st. Separately, analysts at Wedbush raised their price target on shares of Luminex Corp. (NASDAQ:LMNX) from $17.00 to $19.00 in a research note to investors on Thursday, August 1st. They now have a “neutral” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Luminex Corp. (NASDAQ:LMNX) in a research note to investors on Thursday, August 1st. They now have a $21.00 price target on the stock.
One equities research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $21.00.
Shares of Luminex Corp. (NASDAQ:LMNX) traded down 1.78% on Wednesday, hitting $19.85. 55,590 shares of the company’s stock traded hands. Luminex Corp. has a 52-week low of $15.39 and a 52-week high of $24.10. The stock has a 50-day moving average of $20.68 and a 200-day moving average of $19.42. The company has a market cap of $821.7 million and a price-to-earnings ratio of 116.15.
Luminex Corp. (NASDAQ:LMNX) last released its earnings data on Monday, July 29th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.07. The company had revenue of $54.30 million for the quarter, compared to the consensus estimate of $54.16 million. During the same quarter in the previous year, the company posted $0.07 earnings per share. The company’s revenue for the quarter was up 12.5% on a year-over-year basis. Analysts expect that Luminex Corp. will post $0.43 EPS for the current fiscal year.
Luminex Corporation (NASDAQ:LMNX)develops, manufactures and sells biological testing technologies and products with applications throughout the life sciences and diagnostics industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.